Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Fidelio Capital in connection with acquisition of BioMedtrix
Mandate

Vinge advises Fidelio Capital in connection with acquisition of BioMedtrix

March 18, 2020 M&A

Vinge has advised Fidelio Capital on the acquisition of BioMedtrix, LLC. BioMedtrix is a leading company within the market for veterinary orthopedic implants and instruments.

The company is based in New Jersey, USA, and sells its products to over 35 markets world-wide.

Vinge’s team consisted of, among others, Jonas Bergström and Manne Bergström.

Related

Vinge advises Symrise on its public offer for Probi

 Symrise AG has announced a public cash offer to the shareholders of Probi AB (publ) (“Probi”). The offer values Probi at approximately SEK 3,988 million. The shares in Probi are traded on Nasdaq Stockholm, Mid Cap.
November 20, 2024

Vinge advises Oxx in conjunction with an investment in Kodiak Hub

 Kodiak Hub, a Swedish software as a service (SaaS) company, which offers its customers an AI-based software platform, has performed a capital procurement of EUR 6 million. The venture capital fund Oxx, which invests in SaaS companies, is the largest investor.
November 20, 2024

Vinge advises HAKI Safety AB (publ) in connection with the acquisition of Semmco Group Limited

 Semmco Group is a UK market-leading manufacturer and supplier of maintenance platforms and stairs for aircraft and trains.
November 19, 2024